Cincinnati Startup Raises $50 Million to Advance Hypertension Treatment Licensed from Roche

Cincinnati-based CinCor Pharma snagged $50 million in Series A financing, as well as rights to a Roche therapy for treatment-resistant hypertension and primary aldosteronism, a hormonal disorder that can lead to high blood pressure.

Click here to read the complete article.

Story excerpt provided by BioSpace.

Written by Alex Keown.

Originally published May 15, 2019.